These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6752585)
1. Treatment of advanced gastric cancer with 5-fluorouracil versus mitomycin C. Gupta S J Surg Oncol; 1982 Oct; 21(2):94-6. PubMed ID: 6752585 [TBL] [Abstract][Full Text] [Related]
2. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349 [TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C. Krauss S; Sonoda T; Solomon A Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355 [No Abstract] [Full Text] [Related]
4. Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomas. Buroker TR; Kim PN; Baker LH; Ratanatharathron V; Wojtaszak B; Vaitkevicius VK Med Pediatr Oncol; 1978; 4(1):35-42. PubMed ID: 342890 [TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced gastric carcinoma with 5-fluorouracil adriamycin, and mitomycin C (FAM). Haim N; Cohen Y; Honigman J; Robinson E Cancer Chemother Pharmacol; 1982; 8(3):277-80. PubMed ID: 6897021 [TBL] [Abstract][Full Text] [Related]
6. 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer. Bunn PA; Nugent JL; Ihde DC; Cohen MH; Eddy JL; Minna JD Cancer Treat Rep; 1978 Sep; 62(9):1287-93. PubMed ID: 356983 [TBL] [Abstract][Full Text] [Related]
7. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051 [TBL] [Abstract][Full Text] [Related]
8. Gastric cancer: current status of treatment. Carter SK; Comis RL J Natl Cancer Inst; 1977 Mar; 58(3):567-78. PubMed ID: 402478 [TBL] [Abstract][Full Text] [Related]
9. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study. Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837 [No Abstract] [Full Text] [Related]
10. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil]. Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301 [TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer. Cocconi G; DeLisi V; Di Blasio B Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233 [TBL] [Abstract][Full Text] [Related]
13. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer. Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394 [TBL] [Abstract][Full Text] [Related]
15. [Clinical study of 47 patients with stomach cancer treated with mitomycin C]. Paolucci R Cancro; 1971; 24(3):153-9. PubMed ID: 4949673 [No Abstract] [Full Text] [Related]
16. 5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage. Biran H; Sulkes A; Biran S Oncology; 1989; 46(2):83-7. PubMed ID: 2710481 [TBL] [Abstract][Full Text] [Related]
17. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). Douglass HO; Lavin PT; Goudsmit A; Klaassen DJ; Paul AR J Clin Oncol; 1984 Dec; 2(12):1372-81. PubMed ID: 6439836 [TBL] [Abstract][Full Text] [Related]
18. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. MacDonald JS; Woolley PV; Smythe T; Ueno W; Hoth D; Schein PS Cancer; 1979 Jul; 44(1):42-7. PubMed ID: 455263 [TBL] [Abstract][Full Text] [Related]
19. Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C. Cunningham D; Soukop M; McArdle CS; Carter DC; Smyth JF; Allan SG; Kaye SB; Sangster G; Calman KC; Hutcheon AW Br J Surg; 1984 Sep; 71(9):673-6. PubMed ID: 6548166 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM). Oster MW; Gray R; Panasci L; Perry MC Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]